A study looking at the effect positron emission tomography (PET) scans have on the treatment decisions specialists make in patients with suspected cancer of the pancreas.
Phase 2
Recruiting
- Conditions
- Pancreatic and peri-ampullary cancers.Cancer - Pancreatic
- Registration Number
- ACTRN12607000604404
- Lead Sponsor
- Royal Brisbane Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
•Suspected or proven localized pancreatic, ampullary or bile duct malignancy on the basis of standard investigations;
•= 18 years old;
•Deemed suitable, based on tumour stage and medical fitness, to potentially undergo surgery or radiotherapy with curative intent;
•Available for follow up for at least 12 months from the date of PET/CT scanning;
•Able to provide Informed Consent.
Exclusion Criteria
•Claustrophobia;
•Uncontrolled diabetes mellitus;
•Pregnancy;
•Unable to provide informed consent;
•Inability to undergo PET/CT study;
•Any disease, condition, physical examination finding or clinical laboratory finding which, in the opinion of the investigator, makes the patient inappropriate for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Define the percentage of patients in whom, as a result of FDG PET/CT, there is an appropriate change of management plan, treatment strategy or staging.[At the time of staging, at operation or during follow up which is scheduled to occur at 1,3,6,9,12,18,24,30 and 36 months post surgery]
- Secondary Outcome Measures
Name Time Method To compare the staging accuracy of standard imaging alone with the staging accuracy of the combination of standard imaging and PET/CT scanning[At the time of staging, at operation or during follow up which is scheduled to occur at 1,3,6,9,12,18,24,30 and 36 months post surgery];Define the percentage of patients in whom, as a result of FDG PET/CT, there is an inappropriate change of management plan, treatment strategy or staging[At the time of staging, at operation or during follow up which is scheduled to occur at 1,3,6,9,12,18,24,30 and 36 months post surgery]